# Werewolf Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Nov 6, 2025

- Company: [Werewolf Therapeutics, Inc.](/companies/howl.md) (CIK 1785530)
- Form: SCHEDULE 13D/A
- Filed: 2025-11-06
- Accepted by EDGAR: Nov 6, 2025, 16:29 ET
- Period: not reported
- Accession: 0001346824-25-000040
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1785530/000134682425000040/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1785530/000134682425000040/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1785530/000134682425000040/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Nov 6, 2025.
Source: SEC EDGAR, the filing index for accession 0001346824-25-000040. Last ingested by Listed: Nov 14, 2026, 19:15 ET. No prices; not investment advice.
